SEC 13F Intelligence

Managers / Q3 2025 · view latest →

Forefront Analytics, LLC

CIK 0001696802 · ONE TOWER BRIDGE, 100 FRONT STREET, SUITE 1111, WEST CONSHOHOCKEN, PA, 19428 · 6103413900

Reported Value
$104M
Q3 2025
Positions
46
Filings on Record
31
2019–present window
Filed
Nov 21, 2025
original filing

Summary

Forefront Analytics, LLC reported $104M in U.S.-listed holdings across 46 positions for Q3 2025.

Its largest position, ESGD, represents 16.6% of the portfolio.

Compared with Q2 2025, the fund opened 2 new positions and exited 2.

Portfolio Metrics

Turnover
+6.5%
vs prior filed quarter
Top-10 Concentration
+71.8%
share of reported value
Largest Position
+16.6%
Ishares Tr
New / Exited
2 / 2
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $181MQ4 ’18Q1 ’19: $157MQ2 ’19: $235MQ3 ’19: $243MQ4 ’19: $257MQ4 ’19Q3 ’20: $214MQ4 ’20: $230MQ1 ’21: $235MQ2 ’21: $252MQ2 ’21Q3 ’21: $274MQ4 ’21: $299MQ1 ’22: $269MQ2 ’22: $206MQ2 ’22Q3 ’22: $188MQ4 ’22: $188MQ1 ’23: $194MQ2 ’23: $175MQ2 ’23Q3 ’23: $176MQ4 ’23: $203MQ1 ’24: $206MQ2 ’24: $209MQ2 ’24Q3 ’24: $212MQ4 ’24: $215MQ1 ’25: $87MQ2 ’25: $90MQ2 ’25Q3 ’25: $104MQ4 ’25: $113MQ1 ’26: $110Mfilingsflow.com

Portfolio Composition

By security type
ETP: 92.7%Common Stock: 6.7%Other: 0.5%ADR: 0.1%
  • ETP · 92.7% · $96M
  • Common Stock · 6.7% · $7M
  • Other · 0.5% · $487,906
  • ADR · 0.1% · $68,351

Quarter-over-Quarter Changes full breakdown →

vs Q2 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ESGGFLEXSHARES TRNEW+24.4K24.4K+$5M$5M
DHRDANAHER CORPORATIONNEW+1.3K1.3K+$260,281$260,281
ESGDISHARES TRADDED+112.5K185.2K+$11M$17M
ISHARES TRSOLD OUT−7.4K0−$413,496$0
TMOTHERMO FISHER SCIENTIFIC INCSOLD OUT−8910−$361,105$0
MREOMEREO BIOPHARMA GROUP PLCADDED+14.0K33.2K+$16,487$68,351
ZURA BIO LTDTRIMMED−42.5K21.5K+$25,989$93,173
UNHUNITEDHEALTH GROUP INCADDED+3961.1K+$161,009$390,025

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2025

31 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ESGDISHARES TRESG AW MSCI EAFE · MSCI USA MMENTM · CORE HIGH DV ETF · MSCI USA MIN VOL · CORE S&P500 ETF · 3 7 YR TREAS BD · IBOXX HI YD ETF · TIPS BD ETF · GLB INFRASTR ETF · IBOXX INV CP ETF38.80%$40M328.1K
2NUSHARES ETF TRNUVEEN ESG LRGVL10.47%$11M247.9K
3ESGEISHARES INCESG AWR MSCI EM · CUR HD MSCI EM9.85%$10M246.4K
4VANGUARD INTL EQUITY INDEX FFTSE EMR MKT ETF7.14%$7M136.7K
5VANGUARD TAX-MANAGED FDSVAN FTSE DEV MKT6.38%$7M110.5K
6DBX ETF TRXTRACK MSCI EAFE5.35%$6M119.7K
7VTVVANGUARD INDEX FDSVALUE ETF · SMALL CP ETF5.29%$5M26.0K
8ESGGFLEXSHARES TRhistory →STOX GBL ESG SLT4.63%$5M24.4K
9NVDANVIDIA CORPORATIONhistory →COM2.51%$3M14.0K
10SPDR S&P 500 ETF TRTR UNIT1.77%$2M2.8K
11JPMJPMORGAN CHASE & CO.history →COM1.01%$1M3.3K
12WISDOMTREE TRUS SMALLCAP FUND0.96%$1M17.9K
13PROSHARES TRPSHS ULT S&P 500 · PSHS ULTRUSS20000.79%$824,22012.0K
14FIRST TR EXCHANGE-TRADED FDNO AMER ENERGY0.70%$726,00019.0K
15VANGUARD WORLD FDEXTENDED DUR0.63%$651,0009.5K
16DEDEERE & COCOM0.50%$516,0001.1K
17ABTABBOTT LABSCOM0.39%$403,4753.0K
18MEDTRONIC PLCSHS0.38%$394,7334.1K
19UNHUNITEDHEALTH GROUP INCCOM0.38%$390,0251.1K
20EWEDWARDS LIFESCIENCES CORPCOM0.34%$349,3434.5K
21PFEPFIZER INCCOM0.31%$320,49612.6K
22INCYINCYTE CORPCOM0.31%$317,5293.7K
23DHRDANAHER CORPORATIONCOM0.25%$260,2811.3K
24REGNREGENERON PHARMACEUTICALSCOM0.22%$231,831412
254I1PHILIP MORRIS INTL INCCOM0.22%$231,0001.4K
26ZURA BIO LTDCLASS A ORD SHS0.09%$93,17321.5K
27ANNXANNEXON INCCOM0.08%$82,43227.0K
28NKTXNKARTA INCCOM0.08%$81,66639.5K
29GONGERON CORPCOM0.07%$71,59352.3K
30MREOMEREO BIOPHARMA GROUP PLCSPON ADS0.07%$68,35133.2K
31CTMXCYTOMX THERAPEUTICS INCCOM0.06%$57,76818.1K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$110M39May 13, 202613F-HRchanges · EDGAR ↗
Q4 2025$113M47Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$104M46Nov 21, 202513F-HRchanges · EDGAR ↗
Q2 2025$90M47Aug 14, 2025RESTATEMENTchanges · EDGAR ↗
Q1 2025$87M72May 13, 202513F-HRchanges · EDGAR ↗
Q4 2024$215M113Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$212M114Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$209M114Aug 15, 202413F-HRchanges · EDGAR ↗
Q1 2024$206M113May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$203M112Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$176M67Nov 8, 202313F-HRchanges · EDGAR ↗
Q2 2023$175M115Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$194M138May 12, 202313F-HRchanges · EDGAR ↗
Q4 2022$188M130Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022$188M115Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$206M114Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$269M119May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$299M109Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$274M118Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$252M113Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$235M114May 13, 202113F-HRchanges · EDGAR ↗
Q4 2020$230M109Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$214M98Nov 12, 202013F-HRchanges · EDGAR ↗
Q2 2020Under review92Aug 10, 202013F-HRchanges · EDGAR ↗
Q1 2020Under review179May 11, 202013F-HRchanges · EDGAR ↗
Q4 2019$257M77Feb 5, 202013F-HRchanges · EDGAR ↗
Q3 2019$243M76Nov 5, 201913F-HRchanges · EDGAR ↗
Q2 2019$235M69Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$157M69May 13, 201913F-HRchanges · EDGAR ↗
Q4 2018$181M73Feb 12, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • GKFO LLC

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.